NPPA and Hyperglycemia: In contrast, niclosamide and Uro-A aggravated metabolic stress by causing further loss of ψm under hyperglycaemia + P110 (Fig. 5e), confirming their suboptimal safety profile (Supplementary Figs. 7-8).